SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health today unveiled game-changing new features in its flagship software solution, Aperture. As the industry’s most comprehensive platform for life sciences medical teams, Aperture now enables users to leverage patient-centric insights combined with global social media data, impact measurement capabilities, and global insights spanning scientific, bibliometric, and KOL data. These most recent updates extend the value of Aperture’s robust suite of features at a time when data-driven intelligence has never been more crucial.
The new features deliver critical value to Medical Affairs teams through:
- Digital Insights: With an absence of in-person events and meetings due to COVID-19, alternate channels for digital scientific exchange have expanded rapidly. The new social media insight feature in Aperture enables users to pinpoint global HCP discussions on social media channels to identify digital leaders and influencers and support timely, targeted provider communication that can help close gaps in care.
- Global Reach: The addition of global bibliometric, scientific, and KOL data adds deeper insight on medical meetings, clinical trials, scientific publications, advisory boards, editorial boards, regulatory affiliations, and social and digital media sources. These comprehensive sources of intelligence make Aperture the leading global Medical Affairs software platform built for the new digital operating environment.
- Measuring Impact: With its industry-leading impact reporting capabilities, Medical Affairs teams can – for the first time – define their business value and impact, compliantly, on patient populations with the greatest need. This improves Medical Affairs teams’ efforts to close gaps in the community care setting by identifying and engaging HCPs that are responsible for a large volume of relevant patients.
“Aperture is already the best-in-class insights application for Medical Affairs teams, and with these new features we are bringing more signals and global intelligence to enable exceptional patient care,” said Arif Nathoo, MD, CEO and co-founder of Komodo Health. “These capabilities are crucial to Medical Affairs teams as providers increasingly rely on scientific engagement, particularly during the pandemic.”
Additionally, Komodo added telemedicine tagging to Aperture earlier this year. This new feature, powered by Komodo’s Healthcare Map™, provides customers with the ability to better understand practices that are transitioning between in-person and virtual patient management. This insight is particularly important as the country experiences dynamic shifts in how COVID-19’s impact is felt across geographies, settings of care, and differing disease areas in vastly different ways. Looking ahead, Komodo’s 2021 roadmap includes a range of features to help keep Medical Affairs teams on the cutting edge.
Built on Komodo’s Healthcare Map of 320 million patient journeys, Aperture helps close gaps in care by bolstering the power of patient-level data with scientific, scholarly, and social media insights to support a seamless experience for life sciences Medical Affairs teams. Aperture supports use cases from early drug development programs to launch and beyond. Komodo’s portfolio also includes Pulse, a clinical alerting software, and Iris, a commercial strategy software.
About Komodo Health
Komodo Health believes that smarter, more innovative use of data and analytics is essential for reducing disease burden. We apply artificial intelligence and other advanced data science techniques to our first-of-its-kind Healthcare Map™, which tracks the unique patient journeys of over 320 million patients. We empower a multitude of healthcare stakeholders – life science companies, healthcare payers and providers, patient advocacy groups, and others – to create a more cost-effective, value-driven healthcare system. For more information, visit komodohealth.com.
